SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is surging as investors react to the company's recent international expansion into Macau and positive analyst coverage, driving intense speculation about a potential short squeeze. The community is actively debating the significance of upcoming industry conferences and rumors regarding potential government funding, with many traders expressing frustration over coordinated selling pressure while remaining bullish on the firm's long-term pipeline.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure and negative sentiment, with the community actively debating whether the stock's significant pullback represents a generational buying opportunity or a deeper structural decline. Investors are polarized over the company's heavy AI spending and the ongoing volatility, with many expressing frustration over the stock's persistent underperformance compared to the broader tech sector.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is facing intense scrutiny and volatility as the company moves toward a reverse stock split, fueling deep divisions among retail investors. While some holders are speculating on a potential institutional rebound or a short squeeze, many are venting frustration over the lack of positive guidance and are actively positioning themselves to short the stock in anticipation of further downside.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is surging as investors capitalize on a growing natural gas supply crisis triggered by conflict in the Middle East and damage to critical energy infrastructure. Community sentiment remains highly bullish, with active discussions focusing on the stock's potential for a short squeeze, its role as a strategic European LNG supplier, and heavy retail accumulation as volume levels continue to climb.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund (VCX) is seeing intense volatility and record-high trading volume as retail investors react to its direct exposure to high-profile private AI firms like OpenAI, Anthropic, and SpaceX. While bullish sentiment is driven by the fund's unique access to these sought-after holdings, many market participants are actively debating the sustainability of its current market price compared to its intrinsic net asset value, frequently comparing the situation to previous low-float 'pump and dump' market events.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is rallying as investors digest recent earnings, insider buying activity, and strategic AI partnerships, while the community remains divided over whether the stock is primed for a major short squeeze or vulnerable to further downside amid broader software sector volatility.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is experiencing high volatility as investors weigh the long-term potential of its AI-driven enterprise automation platform against broader market fears that AI agents might disrupt traditional software licensing models. Despite recent downward pressure, the stock is seeing significant institutional accumulation, with market participants closely monitoring insider activity and positive commentary from major industry leaders regarding the essential role of ServiceNow's governance and workflow tools in the AI era.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

The RAGE community is driving active engagement by highlighting their position as an OG internet meme, emphasizing their restored original comic-making tools and persistent daily building efforts. Investors are rallying around the ticker as they aim to reclaim cultural mindshare within the crypto sector, viewing the project as a foundational piece of internet history.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is surging as heightened geopolitical tensions in the Middle East and physical damage to major LNG infrastructure in Qatar trigger fears of a severe, long-term global supply shortage. Investors are closely watching the stock for a potential squeeze, with the community highlighting the company's strategic position to capture market share and benefit from elevated spot prices amid ongoing industry disruption.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending as investors react to a significant private placement with RA Capital, providing a crucial cash runway extension through 2026 despite mixed Phase 3 results. Community discussion remains polarized, with many focusing on the disconnect between the symptom endpoint miss and the promising overall survival signal, while others express ongoing frustration regarding the company's financial history and management's strategic execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$HIMS Pay attention to the language folks. Whether it’s an interview on tv or a letter sent to the companies - they keep using the same language over and over and over. Key words: claims, advertisements, marketing. 

This is a marketing issue.

Love

Jamal Anderson

Gdonovan

Hdawg

$LLY $NVO $HIMS  
 
FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s 
 
The U.S. Food and Drug Administration announced the issuance of 30 warning letters to telehealth companies for making false or misleading claims regarding compounded GLP-1 products offered on their websites. &quot;It&#39;s a new era. We are paying close attention to misleading claims being made by telehealth and pharma companies across all media platforms-and taking swift action,&quot; said FDA Commissioner Marty Makary, M.D., M.P.H. &quot;Compounded drugs can be important for overcoming shortages or meeting unique patient needs-but compounders should not try to compound drugs in a way that circumvents FDA&#39;s approval process.&quot; This is the second group of warning letters sent to telehealth firms since the agency launched in September a crackdown on misleading direct-to-consumer pharmaceutical advertisements.  
 
Over the past six months, the agency has sent thousands of letters warning pharmaceutical and telehealth firms to remove misleading ads, more than had been sent over the entire preceding decade. Primary violations identified in the letters included making claims implying sameness with FDA-approved products and obscuring product sourcing by advertising drug products branded with the telehealth firm&#39;s name or trademark without qualification, implying they are the compounder. Publicly traded companies that make GLP-1s include Eli Lilly (LLY) and Novo Nordisk (NVO).  
...

StockTwits Web

Lilly(Eli) & Co

Novo Nordisk A/S

Hims & Hers Health Inc

DonCorleone77

StockTwits for iOS

 Pay attention to the language folks. Whether it’s an interview on tv or a letter sent to the companies - they keep using the same language over and over and over. Key words: claims, advertisements, marketing. 

This is a marketing issue.

Applovin Corp

Super Micro Computer Inc

Carvana Co.

Beyond Meat Inc

AST SpaceMobile Inc

Sweetgreen Inc - Ordinary Shares - Class A

Realbotix Corp.

Dad Suggests Stocks

Palantir Technologies Inc

Robinhood Markets Inc

LifeMD Inc

Tenet Fintech Group Inc

@ClarissaLove And HIMS already fixed it on their website, which is why they aren’t included in this round of letters.

Jewel Gilbert

Cher Farmer

 And HIMS already fixed it on their website, which is why they aren’t included in this round of letters.